SL-172154

SIRPα-Fc-CD40L · Shattuck Labs, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SL-172154, covering 2025-01-30 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML [Phase 1]